EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A DNA Vaccine Incorporating the MHC Class I Trafficking Domain and PADRE Epitope Enhances Antitumor Immunity in a Murine Pancreatic Cancer Model

Simiao Cao, Guoxuan Bai iD, Qimuge Wuri, Jiayin Li, Xiaojing Zhang, Zhilin Han, Hui Wu, Jiaxin Wu, Chu Wang iD, Xianghui Yu iD, Haihong Zhang iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27042039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Simiao Cao und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Laboratory for AIDS Vaccine, School of Life Science, Jilin University, Changchun 130012, China. Hauptthemen laut MEDLINE: Vaccines, DNA, Pancreatic Neoplasms, Cancer Vaccines, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Province Science and Technology Department, Science & Technology Development Plan of Jilin Province, Scientific Research Project of Education Department of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA-based cancer vaccines represent a safe and promising immunotherapeutic strategy, but their clinical efficacy is often limited by weak immunogenicity, primarily due to inefficient antigen cross-presentation. To overcome this challenge, the MHC class I trafficking domain (MITD) can be fused to tumor antigens to enhance their intracellular routing in dendritic cells (DCs), thereby promoting the efficiency of cross-presentation. In addition, incorporation of CD4+ T cell epitopes, such as PADRE or P2P16, can robustly activate CD4+ T cells, further amplifying antitumor immunity. Thus, combining MITD with CD4+ epitopes is expected to synergistically improve DNA vaccine potency. Mesothelin (MSLN), a tumor-associated antigen highly expressed in pancreatic cancer, was selected as the target in this study. We designed MSLN-targeted DNA vaccines incorporating MITD together with either PADRE or P2P16. In a Panc02 murine model, the MITD–PADRE construct, a novel design, elicited stronger immune responses and more effective antitumor activity compared to other formulations. To further counteract immunosuppression, we combined the vaccine with gemcitabine, which enhanced therapeutic efficacy. Together, these findings demonstrate that integrating PADRE with MITD in MSLN-targeted DNA vaccines offers a promising combinatorial strategy for advancing pancreatic cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccines, DNAPancreatic NeoplasmsCancer VaccinesHistocompatibility Antigens Class IEpitopes, T-LymphocyteAnimalsMiceMesothelinDendritic CellsCell Line, TumorGPI-Linked ProteinsDisease Models, AnimalMice, Inbred C57BLFemaleDeoxycytidineGemcitabineHumansAntigens, Neoplasm

Stichwörter der Autor:innen

DNA vaccinesMITDPADREcross-presentationimmunotherapy

Substanzen

Vaccines, DNAMesothelinCancer VaccinesHistocompatibility Antigens Class IMsln protein, mouseEpitopes, T-LymphocyteGPI-Linked ProteinsDeoxycytidineGemcitabineAntigens, Neoplasm

Autor:innen und Institutionen

  • National Engineering Laboratory for AIDS Vaccine, School of Life Science, Jilin University, Changchun 130012, China.
  • Key Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.

ORCID-Profile: Guoxuan Bai, Chu Wang, Xianghui Yu, Haihong Zhang

Förderung

  • Jilin Province Science and Technology Department
  • Science & Technology Development Plan of Jilin Province
  • Scientific Research Project of Education Department of Jilin Province

Zitieren

APA

Cao, S., Bai, G., Wuri, Q., Li, J., Zhang, X., Han, Z., Wu, H., Wu, J., Wang, C., Yu, X., & Zhang, H. (2026). A DNA Vaccine Incorporating the MHC Class I Trafficking Domain and PADRE Epitope Enhances Antitumor Immunity in a Murine Pancreatic Cancer Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27042039

Vancouver

Cao S, Bai G, Wuri Q, Li J, Zhang X, Han Z, et al. A DNA Vaccine Incorporating the MHC Class I Trafficking Domain and PADRE Epitope Enhances Antitumor Immunity in a Murine Pancreatic Cancer Model. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27042039

BibTeX
@article{Cao2026,
  author = {Cao, Simiao and Bai, Guoxuan and Wuri, Qimuge and Li, Jiayin and Zhang, Xiaojing and Han, Zhilin and Wu, Hui and Wu, Jiaxin and Wang, Chu and Yu, Xianghui and Zhang, Haihong},
  title = {A DNA Vaccine Incorporating the MHC Class I Trafficking Domain and PADRE Epitope Enhances Antitumor Immunity in a Murine Pancreatic Cancer Model},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27042039}
}
Kostenlos starten →